ArticleJournal of the National Cancer Institute2024
Defining biology and recurrence risk in prostate cancers treated by neoadjuvant chemohormonal therapy.
Scott Wilkinson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it